Non-Small Cell Lung Cancer With HER2- Mutations
1 clinical trials · Condition
◉ Watch Non-Small Cell Lung Cancer With HER2- Mutations
| Record | Firm | Date |
|---|---|---|
| A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations (NCT06430437) | Jiangsu HengRui Medicine Co., Ltd. | 2024-07-29 |
Track Non-Small Cell Lung Cancer With HER2- Mutations automatically
Every clearance here is in the API, with alerts when new ones post.